NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Tanvex BioPharma Inc (TW: 6541)

 
6541 Technical Analysis
1.5
As on 22nd Nov 2024 6541 STOCK Price closed @ 68.10 and we RECOMMEND Buy for LONG-TERM with Stoploss of 64.06 & Sell for SHORT-TERM with Stoploss of 73.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

6541STOCK Price

Open 68.90 Change Price %
High 69.80 1 Day -1.70 -2.44
Low 67.60 1 Week 4.10 6.41
Close 68.10 1 Month 1.90 2.87
Volume 315003 1 Year -11.50 -14.45
52 Week High 80.50 | 52 Week Low 36.95
 
TW Taiwan Most Active Stocks
9105 8.50 3.79%
3706 83.00 3.88%
2312 32.20 9.90%
2610 24.60 1.86%
2371 52.40 8.26%
2354 82.20 1.61%
2609 77.50 -2.27%
1802 20.65 5.90%
3231 118.50 3.95%
2888 11.70 0.43%
 
TW Taiwan Top Gainers Stocks
8101 13.80 9.96%
8101 13.80 9.96%
3712 69.70 9.94%
1809 23.30 9.91%
1809 23.30 9.91%
2392 79.90 9.90%
2312 32.20 9.90%
2312 32.20 9.90%
1466 14.50 9.85%
1466 14.50 9.85%
 
TW Taiwan Top Losers Stocks
6289 1.35 -10.00%
1587 42.85 -9.98%
1587 42.85 -9.98%
6674 30.20 -4.88%
2867 6.68 -4.30%
5531 11.20 -4.27%
2431 16.45 -4.08%
9928 18.25 -3.95%
9928 18.25 -3.95%
2486 110.50 -3.91%
 
 
6541
Daily Charts
6541
Intraday Charts
Whats New @
Bazaartrend
6541
Free Analysis
 
6541 Important Levels Intraday
RESISTANCE72.34
RESISTANCE70.98
RESISTANCE70.14
RESISTANCE69.30
SUPPORT66.90
SUPPORT66.06
SUPPORT65.22
SUPPORT63.86
 
6541 Forecast November 2024
4th UP Forecast97.78
3rd UP Forecast88.26
2nd UP Forecast82.38
1st UP Forecast76.49
1st DOWN Forecast59.71
2nd DOWN Forecast53.82
3rd DOWN Forecast47.94
4th DOWN Forecast38.42
 
6541 Weekly Forecast
4th UP Forecast72.92
3rd UP Forecast71.37
2nd UP Forecast70.42
1st UP Forecast69.46
1st DOWN Forecast66.74
2nd DOWN Forecast65.78
3rd DOWN Forecast64.83
4th DOWN Forecast63.28
 
6541 Forecast2024
4th UP Forecast156.26
3rd UP Forecast127.99
2nd UP Forecast110.51
1st UP Forecast93.03
1st DOWN Forecast43.17
2nd DOWN Forecast25.69
3rd DOWN Forecast8.21
4th DOWN Forecast-20.06
 
 
6541 Other Details
Segment EQ
Market Capital 17741051904.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
6541 Address
6541
 
6541 Latest News
 
Your Comments and Response on Tanvex BioPharma Inc
 
6541 Business Profile
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. The company's lead product candidate includes TX01 for the treatment of neutropenia. It also develops TX05, which has completed phase III clinical trial for the treatment of breast cancer; TX04 for the treatment of neutropenia; TX16 that has completed phase I clinical trial for the treatment of metastatic colorectal cancer; TX52, which is in pre-clinical trial; and other products. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. Address: 802 West Bay Road, George Town, Cayman Islands, KY1-1205
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service